"Positive Outcomes of Weight-loss Drugs Post Hip Replacement Surgery"

Preliminary data presented at a meeting of orthopedic surgeons suggests that new diabetes and weight-loss drugs like Ozempic (semaglutide) may benefit patients undergoing hip replacement by reducing the risk of infection and readmission to the hospital without increasing postoperative complication risks. However, more evidence from high-quality, prospective, randomized controlled trials is needed before definitively recommending the use of these drugs prior to total hip replacement.